• Pharma
  • December 22, 2020
  • 2 views
AstraZeneca Pharma gets DCGI nod to market asthma drug

NEW DELHI: Drug firm AstraZeneca Pharma on Monday said it has received marketing authorisation from Drug Controller General of India for Benralizumab solution, indicated as an add-on maintenance treatment for severe asthma. AstraZeneca Pharma India Ltd has received import…

  • Health
  • October 2, 2019
  • 4 views
Maharashtra Directorate of Health Services ban Ranitidine use in govt hospitals until further notice

In India, over 180 products based on ranitidine are sold by various leading drug makers with market size of about Rs 750 crore. Ranitidine, an old molecule, is prescribed for intestinal…